According to a recent analysis by Emergen Research, the global market for next-generation sequencing is anticipated to reach USD 23.59 billion by 2027.
According to a recent analysis by Emergen Research, the global market for next-generation sequencing is anticipated to reach USD 23.59 billion by 2027. One of the key forces behind the Next Generation Sequencing (NGS) industry is the advantages of high-performance sequencing over earlier generations, such as sanger-seq and microarrays. Thus, it is anticipated that the improved accessibility of low input DNA sample techniques would hasten the use of next-generation sequencing in a variety of clinical and research contexts.
Global adoption of the newest NGS technologies has been significantly enhanced by the low cost of genome sequencing combined with the availability of high-end, effective, and accurate NGS devices. With the introduction of the iSeq benchtop sequencer in 2018, Illumina, for instance, offered NGS genome sequencing at a price of about USD 100 (with a sequencing cost of USD 25–150 per sample). This launch occurred soon after the NovaSeq platform, which allows genome sequencing at USD $1,000, was released in 2017. (as of 2018). Additionally, the next-generation sequencing industry is anticipated to gain from the growth of genomics projects in a number of nations. Next-generation sequencing-based diagnostics are now available, and proactive government backing is one of the main drivers of market expansion.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/8
The order of the nucleotides in the entire genome can be determined using next-generation sequencing (NGS), a massively parallel sequencing method that offers scalability, ultra-high throughput, and fast speed. As it includes preparing the material for the subsequent sequencing reaction, DNA pre-sequencing is one of the most important processes in the overall sequencing protocol.
Genome mapping initiatives, applications of next-generation sequencing, healthcare spending, and technological improvements in sequencing platforms all contribute to the growth of the global market for next-generation sequencing. One such example is the Ion Torrent Genexus System, a next-generation platform that delivers the specimen to report in just one day, which was introduced in 2019 by Thermo Fisher Scientific, a global leader in providing science services.
Some Key Highlights from the Report
- Some institutions or businesses lack the necessary infrastructure to conduct sequencing operations. Additionally, outsourcing the NGS project is a time- and money-effective substitute for hiring personnel with specialised skill sets and establishing the infrastructure required to carry out NGS effectively in situations where just a small number of samples need to be sequenced. As a result, the market is seeing an increasing trend of corporations outsourcing sequencing to them at low costs.
- In 2020, the NGS market’s second-largest share belonged to the drug discovery sector. The number of agreements, partnerships, and collaborations between NGS market participants, academic institutions, and pharmaceutical companies for drug development, as well as the expanding use of NGS during clinical trials for drug discovery and development, are what are propelling the growth of this application segment.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/next-generation-sequencing-market
- In 2021, the targeted sequencing and resequencing market had the biggest share (74.9%). Following the advent of whole genome sequencing, this market is anticipated to experience increased demand as a result of the need to examine massive amounts of whole genome data at particular gene regions and separated genetic expressions. Targeted sequencing services are provided by a large number of businesses in the NGS sector. As a result, it is anticipated that during the projected period, this segment will increase with the WGS segment.
- The market’s largest revenue share for next-generation sequencing applications was predicted to go to cancer. This may be due to the technology’s extensive usage in establishing the genetic basis of cancer.
- Academic research accounted for the greatest market share in 2019 (53.9%), and these organisations are the main sources of revenue due to the widespread use of seq-technology in research. On the other hand, this technology is always improving in clinical settings and clinical research.
- The region’s market is expanding as a result of favourable initiatives by public and private organisations for the development and adoption of NGS technologies, widespread use of NGS diagnostics, an increase in the number of NGS-based clinical applications in the region, expanding cancer research, and growing public awareness of NGS services.
- Important collaborators in the project include, among others, DeLaval, Antelliq, Heliospectra, Afimilk Ltd., InnovaSea Systems, AKVA group, and Nexus Corporation.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/8
Emergen Research has segmented the global Next Generation Sequencing Market on the basis of technology, workflow, application, end-use, and region:
Technology Outlook (Revenue, USD Billion; 2017-2027)
- Whole Genome Sequencing
- Whole Exome Sequencing
- Targeted Sequencing & Resequencing
Workflow Outlook (Revenue, USD Billion; 2017-2027)
- Pre-sequencing
- Sequencing
- NGS Data Analysis
Application Outlook (Revenue, USD Billion; 2017-2027)
- Clinical Investigation
- Oncology
- Reproductive Health
- HLA Typing/Immune System Monitoring
- Metagenomics, Epidemiology & Drug Development
- Agrigenomics & Forensics
- Consumer Genomics
End-Use Outlook (Revenue, USD Billion; 2017-2027)
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Others
- Regional Outlook (Revenue, USD Billion; 2019–2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
- North America
Make an Inquiry Before Buying@ https://www.emergenresearch.com/purchase-enquiry/8
Explore More Reports Emergen Research:
AI-based Clinical Trials Solution Provider Market
Personalized Therapy Biosimulation Market
Clinical Trial Software Market
CRISPR/CAS 9 Technology Market
Endometrial Ablation Devices Market
Antibody Drug Conjugates Market
Implantable Cardioverter Defibrillator Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-next-generation-sequencing-market